Details and Advantages
Applications:
ELISA,Flow Cyt
Reactivity:
Human KDR/CD309/VEGFR2
Conjugate:
Unconjugated
Advantages:
High lot-to-lot consistency
Increased sensitivity and higher affinity
Animal-free production
概述
>
Description:
Anti-KDR/VEGFR2(Olinvacimab Biosimilar) Antibody is a biosimilar antibody directed against Human KDR/CD309/VEGFR2.
Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Human KDR/CD309/VEGFR2
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Anti-KDR/VEGFR2(Olinvacimab Biosimilar) Antibody is a biosimilar antibody directed against Human KDR/CD309/VEGFR2.
Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Human KDR/CD309/VEGFR2
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
性能
>
ELISA: 1:5000-1:20000
Flow Cyt: 1:200-1:1000
Other tested applications.
Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.
